Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Feb 10, 2025 (2 years ago)

Sodium Chloride Injection 9%

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Sodium Chloride Injection 9%, USP, 500 mL, Single-Dose IV Bottle, Rx Only, nephron, 503B outsourcing facility, West Columbia, SC 29172, NDC: 69374-334-50

Affected NDC 69374-0334-50

Compare with the code on your package — it is the most precise check available.

Recalling firm
Nephron Sterile Compounding Center LLC
Origin
SC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0257-2025 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Nephron Sterile Compounding Center LLC

All 2025 recalls

Other sterility / contamination recalls from 2025

All sterility / contamination recalls
Class II · Moderate risk

Vista Gonio Eye Lubricant

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Ongoing Sterility / contamination Wizcure Pharmaa Private Limited NDC 77790-022-15 D-0349-2026